Clinical Trial Update: 18F-FDG PET/CT Imaging for Breast Cancer [NA]

View source ↗

Summary

This clinical trial is investigating 18F-FDG PET/CT imaging for breast cancer (including recurrent disease) and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fluorodeoxyglucose (18F-FDG) (Fluorodeoxyglucose)

Snippet

Sponsor: Vestre Viken Hospital Trust | Conditions: Breast Cancer Female, Breast Cancer Recurrent | NA | Status: RECRUITING